{
    "eid": "2-s2.0-85163784249",
    "title": "Plasma and Urine Pharmacokinetics of Oral Fosfomycin Tromethamine in Dogs",
    "cover-date": "2023-06-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Veterinary (all)",
            "@code": "3400",
            "@abbrev": "VETE"
        }
    ],
    "keywords": [
        "dogs",
        "Fosfomycin tromethamine",
        "liquid chromatography tandem mass spectrometry (LC- MS/MS)",
        "pharmacokinetic",
        "plasma",
        "urine"
    ],
    "authors": [
        "Nattha Jariyapamornkoon",
        "Koranis Patthanachai",
        "Nipattra Suanpairintr"
    ],
    "citedby-count": 0,
    "ref-count": 49,
    "ref-list": [
        "Phosphonomycin, a new antibiotic produced by strains of streptomyces",
        "Molecular Mechanisms and Clinical Impact of Acquired and Intrinsic Fosfomycin Resistance",
        "The mechanism of action of fosfomycin (phosphonomycin)",
        "MurA (MurZ), the enzyme that catalyzes the first committed step in peptidoglycan biosynthesis, is essential in Escherichia coli",
        "Antibacterial spectrum of fosfomycin trometamol",
        "Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods",
        "Antimicrobial susceptibility of Gram-negative nonurinary bacteria to fosfomycin and other antimicrobials",
        "Fosfomycin",
        "Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: A systematic review",
        "In vitro susceptibility of canine and feline Escherichia coli to fosfomycin",
        "Pharmacokinetic study of fosfomycin and its bioavailability",
        "Acid-catalyzed hydrolysis of fosfomycin and its implication in oral absorption of the drug",
        "Mechanisms of intestinal absorption of the antibiotic, fosfomycin, in brush-border membrane vesicles in rabbits and humans",
        "Fosfomycin: Pharmacological, Clinical and Future Perspectives",
        "Pharmacokinetic profile of fosfomycin trometamol",
        "Pharmacokinetic profile of fosfomycin trometamol (Monuril)",
        "Phase I Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adult Participants",
        "Pharmacokinetics of disodium-fosfomycin in mongrel dogs",
        "Pharmacokinetics of fosfomycin",
        "Fosfomycin: Uses and potentialities in veterinary medicine",
        "Degree of absorption, pharmacokinetics of fosfomycin trometamol and duration of urinary antibacterial activity",
        "Fosfomycin: Mechanism and Resistance",
        "Pharmacokinetics and time dependent killing of fosfomycin in multi drug resistant-Escherichia coli urinary tract infections in dogs. Research Abstract Program of the 2011 ACVIM Forum Denver, Colorado, June 15\u201318, 2011",
        "Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections",
        "Urinary Pharmacokinetic and Pharmacodynamic Profiles of Fosfomycin against Extended-Spectrum beta-Lactamase-Producing Escherichia coli with Canine Ex Vivo Modeling: A Pilot Study",
        "Pharmacokinetics and bioavailability of calcium fosfomycin in post weaning piglets after oral administration",
        "Fosfomycin distribution in the lower urinary tract after administration of fosfomycin trometamol salt",
        "Fosfomycin: Absorption and excretion",
        "Volume of Distribution in Drug Design",
        "Assessment of renal function",
        "Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers",
        "Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection",
        "Oral Fosfomycin Efficacy with Variable Urinary Exposures following Single and Multiple Doses against Enterobacterales: The Importance of Heteroresistance for Growth Outcome",
        "A fast and sensitive LC-MS/MS method for the quantification of fosfomycin in human urine and plasma using one sample preparation method and HILIC chromatography",
        "The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics",
        "In Vivo Pharmacokinetics and Pharmacodynamics of ZTI-01 (Fosfomycin for Injection) in the Neutropenic Murine Thigh Infection Model against Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa",
        "Pharmacodynamic Evaluation of Fosfomycin against Escherichia coli and Klebsiella spp. from Urinary Tract Infections and the Influence of pH on Fosfomycin Activities"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Chulalongkorn University"
    ]
}